UK organisations working with research organisations can apply for a share of up to £30 million to support the creation of a network of advanced therapies treatment centres.

Innovate UK is to invest up to £30 million to establish a network of 3 advanced therapies treatment centres in the UK.

Proposals should:

• increase patient access to advanced therapy medicinal products (ATMPs) on a national level
• establish best practice for the safe and effective delivery of ATMPs to patients
• establish best practice for the manufacturing and final preparation of ATMPs using Good Manufacturing Practice (GMP) within a clinical setting
• establish robust connected supply chains for the manufacture and delivery of ATMPs
• create systems to allow traceability and tracking of ATMPs. These must be compatible with current regulations and be suitable for applying across the NHS
  establish best practice for patient follow up and data capture

All of the centres that receive funding will form a network. This will be co-ordinated through the Cell and Gene Therapy Catapult.

The 3 successful centres will eligible to apply for up to £6 million of additional funding in 2018 for network projects and related activities.

Competition opens: Friday 29 September 2017
Competition closes: Wednesday 1 November 2017 12:00pm